NCT02581007 · OUTCOME

Relapse Incidence

Reduced Intensity Conditioning Transplant Using Haploidentical Donors · Source last updated 2023-04-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: percentage of patients
Interval / dispersion: 95% Confidence Interval
Time frame: 2 years

What was measured

Number of patients with disease reoccurrence at 1 and 2 years post-transplant

Groups in this outcome

Reduced-Intensity Mismatched Transplant

Fludarabine, Melphalan \& Post-transplant cyclophosphamide Fludarabine: fludarabine (30mg/m2) given every day starting on Day -6 through Day -2; Melphalan Cyclophosphamide: cyclophosphamide (50mg/kg) given every day starting on Day 3 through Day 4. peripheral blood stem cell transplant

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Reduced-Intensity Mismatched Transplant	25

Reported measurements

1 yr post-transplant

Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
Reduced-Intensity Mismatched Transplant	24	Not reported	10	42	Not reported

2 yr post-transplant

Values in percentage of patients · Interval/dispersion: 95% Confidence Interval
Group	Value	Spread	Lower	Upper	Comment
Reduced-Intensity Mismatched Transplant	36	Not reported	17	55	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
lower Limit
10
upper Limit
42
value
24
title
1 yr post-transplant
categories
measurements
group Id
OG000
lower Limit
17
upper Limit
55
value
36
title
2 yr post-transplant

denoms

counts
group Id
OG000
value
25
units
Participants

description

Number of patients with disease reoccurrence at 1 and 2 years post-transplant

dispersion Type

95% Confidence Interval

groups

description
Fludarabine, Melphalan \& Post-transplant cyclophosphamide Fludarabine: fludarabine (30mg/m2) given every day starting on Day -6 through Day -2; Melphalan Cyclophosphamide: cyclophosphamide (50mg/kg) given every day starting on Day 3 through Day 4. peripheral blood stem cell transplant
id
OG000
title
Reduced-Intensity Mismatched Transplant

param Type

NUMBER

reporting Status

POSTED

time Frame

2 years

title

Relapse Incidence

type

SECONDARY

unit Of Measure

percentage of patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice